Madrona Financial Services LLC Has $4.24 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Madrona Financial Services LLC grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 786.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 32,075 shares of the financial services provider’s stock after purchasing an additional 28,457 shares during the quarter. iShares Biotechnology ETF comprises 1.2% of Madrona Financial Services LLC’s portfolio, making the stock its 24th biggest holding. Madrona Financial Services LLC owned approximately 0.07% of iShares Biotechnology ETF worth $4,241,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BNP Paribas Financial Markets grew its position in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares in the last quarter. Commerce Bank boosted its holdings in iShares Biotechnology ETF by 1.8% during the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after purchasing an additional 12,921 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after purchasing an additional 164,000 shares in the last quarter. Main Management ETF Advisors LLC boosted its holdings in iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after purchasing an additional 14,535 shares in the last quarter. Finally, Aprio Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $18,476,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.4 %

NASDAQ IBB opened at $135.78 on Thursday. The stock’s 50 day moving average is $136.00 and its two-hundred day moving average is $141.81. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.